Patent · US Active

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

US9303087B2 · kind B2 · utility

1Cited by
2References
92Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2014
Grant dateApr 5, 2016
Priority date—
Expiry dateSep 15, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Monoclonal antibodies against LRP6 and that block the Wnt signaling pathway are disclosed. Methods of production and use thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.